KJIM :: Korean Journal of Internal Medicine

Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023

Carlos Abud-Mendoza, Francisco Javier Aceves-Ávila, César Alejandro Arce-Salinas, José Álvarez Nemegyei, Leonor Barile-Fabris, Sergio Durán-Barragán, Diana Elsa Flores-Alvarado, Eufrates Hernández-Núñez, Fedra Irazoque-Palazuelos, José Francisco Moctezuma

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023

Reumatología Clínica (English Edition).2024; 20(5): 263. CrossRef

Interleukin-receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases

Arturo J Martí-Carvajal, Mario A Gemmato-Valecillos, Diana Monge Martín, Mark Dayer, Eduardo Alegría-Barrero, Juan Bautista De Sanctis, Juan Marcos Parise Vasco, Ricardo J Riera Lizardo, Susana Nicola, Cristina Elena Martí-Amarista, Andrea Correa-Pérez

Cochrane Database of Systematic Reviews.2024;[Epub] CrossRef

Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs

Dala N Daraghmeh, Ashley M Hopkins, Catherine King, Ahmad Y Abuhelwa, Mihir D Wechalekar, Susanna M Proudman, Michael J Sorich, Michael D Wiese

Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents

Xin Zhao, Chenhao Zhang, Yi An, Zixuan Zhang, Jiahe Zhao, Xinwen Zhang, Yue Yang, Wei Cao

Journal of Inflammation Research.2023; Volume 16: 443. CrossRef

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis

Masanori A. Murayama, Jun Shimizu, Chie Miyabe, Kazuo Yudo, Yoshishige Miyabe

Targeting IL-6 Signaling Pathways for Musculoskeletal Disorders Treatment: Risks and Benefits

Aisha Muthanna Shanshal, Raghda Hisham Aljorani, Saad Abdulrahman Hussain

Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ).2023; 4: 34. CrossRef

Comparative Efficacy of bDMARDs and tsDMARDs for the Treatment of Rheumatoid arthritis: A Systematic Review and Network Meta-Analysis

International Journal of Biology and Life Sciences.2023; 3(1): 35. CrossRef

Effectiveness of biologics and targeted synthetic disease‐modifying anti‐rheumatic drugs in conjunction with methotrexate for the treatment of early rheumatoid arthritis: A systematic review of randomized controlled trials

Sadia Laeeq, Tiba Reghefaoui, Hafsa Zahoor, Ji Hyun Yook, Muneeba Rizwan, Noor ul ain Shahid, Noreen Naguit, Rakesh Jakkoju, Lubna Mohammed

Evaluation of Treatment with a single (400mg) versus double dose (800mg) of Tocilizumab in Acute Respiratory Distress Syndrome Associated with COVID-19Pneumonia

Journal of Contemporary Medicine.2022; 12(1): 134. CrossRef

Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study

Jina Yeo, Han Joo Baek, Yeong Wook Song, Eun Young Lee

Journal of Rheumatic Diseases.2022; 29(2): 89. CrossRef

Predictive Factors for Rheumatoid Arthritis Flare After Switching From Intravenous to Subcutaneous Formulation of Tocilizumab in Real-World Practice

Soo Min Ahn, Ji Seon Oh, Hyun Mi Heo, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim

Journal of Korean Medical Science.2022;[Epub] CrossRef

Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China

Yan Wei, Jin Zhao, Jian Ming, Xuewu Zhang, Yingyao Chen

Patient Preference and Adherence.2022; Volume 16: 2387. CrossRef

A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases

Kastriot Kastrati, Daniel Aletaha, Gerd R Burmester, Eva Chwala, Christian Dejaco, Maxime Dougados, Iain B McInnes, Angelo Ravelli, Naveed Sattar, Tanja A Stamm, Tsutomu Takeuchi, Michael Trauner, Desirée van der Heijde, Marieke J H Voshaar, Kevin Winthro

Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies

Sweety Sharma, Somnath Basu, Ramesh K. Goyal, Parbhat K. Sahoo, Rajani Mathur

Journal of Pharmacology and Pharmacotherapeutics.2022; 13(4): 330. CrossRef

The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus

Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee

The Korean Journal of Internal Medicine.2020; 35(1): 41. CrossRef

The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus

Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee

Journal of Rheumatic Diseases.2020; 27(1): 4. CrossRef

Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of their Treatment Response: a Retrospective Cohort Study

In Ah Choi, Akira Sagawa, Eun Young Lee, Eun Bong Lee, Yeong Wook Song

Journal of Korean Medical Science.2020;[Epub] CrossRef

Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature

Luca Bernardo, Stefania Del Sesto, Laura Giordano, Anna Rita Benincaso, Piero Biondi, Vinicio Goj, Francesca Ferrara, Antonella Talenti, Antonella Grisolia, Paolo Antonio Ascierto

Drugs & Therapy Perspectives.2020; 36(12): 568. CrossRef

Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications

Sarah Patterson, Gabriela Schmajuk, Michael Evans, Ishita Aggarwal, Zara Izadi, Milena Gianfrancesco, Jinoos Yazdany

The Joint Commission Journal on Quality and Patient Safety.2019; 45(5): 348. CrossRef

Disseminated nocardiosis with Nocardia brasiliensis bacteremia in a patient with rheumatoid arthritis using tocilizumab

Ryosuke Yamate, Takashi Matono, Takashi Yaguchi, Yusuke Fujii, Yuki Goto, Kazunori Tobino, Hiroshi Imura, Shuji Nagano

Journal of Infection and Chemotherapy.2019; 25(7): 552. CrossRef

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors

Jawad Bilal, Adam Berlinberg, Irbaz Bin Riaz, Warda Faridi, Sandipan Bhattacharjee, Gilbert Ortega, Mohammad H. Murad, Zhen Wang, Larry J. Prokop, Abdullah A. Alhifany, C. Kent Kwoh

Early Response of DAS28-ESR (3) Predicts Sustained Response to Tocilizumab Switched from Abatacept

Takayasu Ando, Takeshi Suzuki, Yutaka Gotou, Mitsuru Imamura, Hiroko Nagafuchi, Yoshioki Yamasaki, Seido Ooka, Kimito Kawahata

Journal of St. Marianna University.2019; 10(2): 39. CrossRef